The FDA has approved the REZA BAND from Somna Therapeutics, according to a new report.
The REZA BAND applies slight pressure to the neck to reduce laryngopharyngeal reflux symptoms. In clinical trials, 86 percent of patients were found to have significant symptom reduction after two weeks, according to the company.
AdvertisementReza Shaker, MD, chief of gastroenterology and hepatology at Froedtert & The Medical College of Wisconsin in Milwaukee, is one of the founders of Somna Therapeutics.
It works by applying pressure to the cricoid cartilage area right below the laryngeal prominence, squeezing the upper esophageal sphincter and preventing the movement of acid up the esophagus.
This relieves the larynx, pharynx, and the lungs from being affected by reflux coming from the stomach. The REZA BAND is most applicable for night time use, adjusted by the user to be comfortable on the neck during sleep.
The device has considerable evidence pointing to its effectiveness, with 86% of patients studied having a reduction in symptoms after two weeks, while 92% of physicians approving of the technology.